Indian drug giant Sun Pharma has lined up an $11.75 billion acquisition of Organon, a women’s health and biosimilar maker spun out of Merck in 2021.
The all-cash deal came in at $14 per share …
The FDA is launching a pilot program to collect and review clinical trial data in real time, giving scientific reviewers access to the data as
A few years in, admin tech is still reigning as the king of health tech funding. Startups using AI to tackle mundane administrative work in
Pfizer is staving off Vyndamax competition for another two years. The drug, also known as tafamidis, is among Pfizer’s top three best-selling medicines and vaccines.
When the Supreme Court hears arguments this week over a prescription-strength pill derived from fish oil, the entire generic drug industry will be watching. The
Merck KGaA has started working with Remepy on the development of hybrid drugs that combine medicines with digital therapeutics.
Indian drug giant Sun Pharma has lined up an $11.75 billion acquisition of Organon, a women’s health and biosimilar maker spun out of Merck in 2021.
The all-cash deal came in at $14 per share …